ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 6969

$631K Total Retail Price of All Prescriptions

Rank: 365 out of 6969

770 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 770 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,834 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 840 713 1 2
SIMVASTATIN 789 675 2 1
LOVASTATIN 689 657 3 15
METFORMIN HCL 685 519 4 7
OMEPRAZOLE 679 594 5 6
LEVOTHYROXINE SODIUM 642 530 6 5
GABAPENTIN 515 412 7 17
ATENOLOL 483 404 8 9
AMLODIPINE BESYLATE 404 358 9 4
HYDROCODONE-ACETAMINOPHEN 340 259 S3 10 3
GLIPIZIDE 329 290 11 21
HYDROCHLOROTHIAZIDE 313 269 12 8
FUROSEMIDE 290 269 13 10
PANTOPRAZOLE SODIUM 270 223 14 31
LOSARTAN POTASSIUM 267 244 15 12
GLIMEPIRIDE 235 185 16 44
DIOVAN 213 176 17 26
METOPROLOL TARTRATE 213 163 17 13
WARFARIN SODIUM 194 180 19 20
SERTRALINE HCL 183 143 20 38
DONEPEZIL HCL 164 164 21 32
PRAVASTATIN SODIUM 156 121 22 19
BENAZEPRIL HCL 156 133 22 18
ATORVASTATIN CALCIUM 153 126 24 11
PAROXETINE HCL 150 125 25 65
DIOVAN HCT 147 143 26 57
TRAMADOL HCL 146 120 27 27
FAMOTIDINE 139 123 28 37
TERAZOSIN HCL 130 125 29 49
CAPTOPRIL 130 130 29 226
ALENDRONATE SODIUM 129 122 31 14
LANTUS 120 74 32 50
ACTOS 116 95 33 61
MELOXICAM 115 96 34 36
CLOPIDOGREL 109 95 35 48
NAMENDA 109 109 35 51
FLUOXETINE HCL 101 83 37 43
ZOLPIDEM TARTRATE 92 70 38 16
TRAZODONE HCL 90 78 39 47
LOSARTAN-HYDROCHLOROTHIAZIDE 88 85 40 53
GLYBURIDE 87 85 R 41 54
VERAPAMIL ER 82 81 42 133
TRIAMTERENE-HCTZ 82 82 42 58
MIRTAZAPINE 81 64 44 76
DOXAZOSIN MESYLATE 80 72 45 74
IBUPROFEN 79 57 46 29
GEMFIBROZIL 79 70 46 85
POTASSIUM CHLORIDE 78 65 48 30
DILTIAZEM ER 77 76 49 206
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 65 50 28
PLAVIX 76 67 50 68
CITALOPRAM HBR 73 44 52 34
CIPROFLOXACIN HCL 69 63 53 64
PROAIR HFA 69 59 53 33
FLUTICASONE PROPIONATE 68 49 55 24
CARVEDILOL 67 66 56 25
ALLOPURINOL 64 64 57 35
ENALAPRIL MALEATE 64 56 57 56
TAMSULOSIN HCL 63 61 59 23
METOPROLOL SUCCINATE 63 63 59 22
CLONIDINE HCL 59 59 61 59
TRIAMCINOLONE ACETONIDE 59 35 61 55
SPIRONOLACTONE 55 28 63 102
FENOFIBRATE 54 39 64 63
GLYBURIDE-METFORMIN HCL 51 37 R 65 92
RANITIDINE HCL 51 48 65 46
NIFEDIPINE ER 51 51 65 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.